The Global Preventive Vaccines Market Is Projected To Be Worth Usd 94 Billion By 2030, Growing At A Cagr Of 10.7%, Claims Roots Analysis

By Author: jameshebrew
Total Articles: 15
Comment this article

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2020-2030”.

The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:
A detailed assessment of the current market landscape, featuring clinical-stage preventive vaccines.
A competitiveness analysis of preventive vaccine developers, featuring insightful pictorial summaries and representations.
Elaborate profiles of the key preventive vaccine developers (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific.
An in-depth analysis of the completed, ongoing and planned trials of various preventive vaccines.
An overview of the ongoing vaccine development initiatives for complex conditions, such as COVID-19, Ebola virus disease, HIV/AIDS, malaria and zika virus ...
... infection.
An analysis of the investments made in this domain, during the period between 2015 and 2020 (till March).
A case study on contract manufacturing landscape for vaccines, featuring the CMOs engaged in this domain.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

To request for sample - https://www.rootsanalysis.com/reports/318/request-sample.html

Route of Administration
Intramuscular
Subcutaneous
Oral
Intravenous
Others

Type of Vaccine
Pneumococcal Conjugate Vaccine
Human Papilloma Virus Vaccine
Rotavirus Vaccine
Influenza Vaccine
MMR Vaccine
Tetanus and Diphtheria Booster Vaccine
Varicella Vaccine
DTaP-Hib-IPV Vaccine
DTaP-HepB-Hib-IPV Vaccine
Others

Type of Vaccine API
Live, Attenuated Vaccine
Inactivated Vaccine
Conjugate Vaccine
Subunit Vaccine
Toxoid Vaccine
Others
Target Patient Population
Pediatric Patients
Adults

Key Players
GlaxoSmithKline
Merck
Sanofi Pasteur
Pfizer
Emergent BioSolutions
CSL
Others

Key Geographical Regions 
North America
Europe
Asia Pacific
Rest of the World 

Key companies covered in the report
Bio Farma
Emergent BioSolutions
GC Pharma
GlaxoSmithKline
Janssen
Merck
Novavax
Pfizer
Sanofi Pasteur
Valneva

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

Other Recent Offerings
Novel coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
Novel Vaccine Delivery Devices Market, 2019-2030 [COVID-19 SERIES]
Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030 [COVID-19 SERIES]

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis